All Posts: triple-negative breast cancer
2 Articles
- GUMC Stories
ISPY2: A Unique, Flexible Breast Cancer Trial for Modern Times
The ISPY2 breast cancer clinical trial is a unique phase 2 study that offers a broad range of treatment options for patients with locally advanced breast.…
August 16, 2024
- GUMC Stories
Clinical Trial Result Leads to New Treatment Option for Hard-to-Treat Breast Cancer
…
June 4, 2021